Trials / Completed
CompletedNCT03696628
Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells (DMDstem)
Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 0 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
Interventional, cross-sectional biomedical study of children with genetic cardiomyopathy and healthy children. The aim is to generate, via induced human pluripotent stem cells (hiPSC), "patient-specific" cardiomyocytes (CMs) (hiPSC-CMs) to study the molecular mechanisms of cardiomyopathies of genetic origin.
Detailed description
Interventional, cross-sectional biomedical study of children with genetic cardiomyopathy and healthy children. The aim is to generate, via induced human pluripotent stem cells (hiPSC), "patient-specific" cardiomyocytes (CMs) (hiPSC-CMs) to study the molecular mechanisms of cardiomyopathies of genetic origin. The study will be proposed to the parents or legal guardians of the children from 0 to 17 included sent in pediatric cardiology consultation to the University Hospital of Montpellier as part of their usual follow-up or a health check (control) . The only direct intervention performed on the patient is a venous blood sample. The volume of blood collected will be lower than the thresholds defined in the Decree of December 2nd, 2016 on minimal risks in biomedical research (3 ml).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Electrocardiogram | heart testing |
| OTHER | physical examination | done by the investigator |
| OTHER | echocardiography | heart testing |
| BIOLOGICAL | blood test | A sample of blood will be taken to each patient or healthy children in order to generate hiPSC-cardiomyocytes |
Timeline
- Start date
- 2017-09-25
- Primary completion
- 2021-01-20
- Completion
- 2021-01-20
- First posted
- 2018-10-04
- Last updated
- 2022-12-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03696628. Inclusion in this directory is not an endorsement.